Real-World check: Talzenna's safety and effectiveness under the microscope
NCT ID NCT04982848
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 26 times
Summary
This study tracks 600 people in Korea with advanced breast cancer and a BRCA gene mutation who are prescribed Talzenna by their doctor. Researchers will watch for side effects and measure how well the drug controls the cancer in real-life settings, not a lab. The goal is to confirm the drug's safety and effectiveness outside of clinical trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.